2018
DOI: 10.2174/2211738505666170301142232
|View full text |Cite
|
Sign up to set email alerts
|

C60-fullerenes as Drug Delivery Carriers for Anticancer Agents: Promises and Hurdles

Abstract: The drug release rate controlling behavior, higher drug loading, immuno-neutrality, substantial biocompatibility, capability to bypass mononuclear phagocytic system, long circulating nature and tissue extraction by virtue of enhanced permeability and retention effect are the major promises of these nanocarriers. On the other hand, the concerns like elimination from the biological system, anticipated tissue toxicity, stability of the final product, sterility issues and commercial viability pose challenges in pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 0 publications
0
35
0
Order By: Relevance
“…This task can be addressed with means of nanobiotechnology. Recent progress in this field has arisen interest in a carbon nanostructure — C 60 fullerene [1] that not only exhibits unique physicochemical properties [2, 3], biological activity [410] and antioxidant behavior [1114], but also possesses a significant potential to serve as a nanocarrier for drug delivery into cancer cells [1525] (here consistently abbreviated as “C 60 ”).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…This task can be addressed with means of nanobiotechnology. Recent progress in this field has arisen interest in a carbon nanostructure — C 60 fullerene [1] that not only exhibits unique physicochemical properties [2, 3], biological activity [410] and antioxidant behavior [1114], but also possesses a significant potential to serve as a nanocarrier for drug delivery into cancer cells [1525] (here consistently abbreviated as “C 60 ”).…”
Section: Introductionmentioning
confidence: 99%
“…The anticancer anthracycline chemotherapeutic drug Doxorubicin (here abbreviated consistently as “Dox”) is one of the first candidates for a more targeted nanodelivery due to life-threatening cardiotoxicity and other serious side effects [25, 26]. The main mechanism of Dox toxicity against cancer cells is its intercalation into nuclear DNA followed by inhibition of topoisomerase activity, DNA replication, and repair [2628].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Carbon-based NMs have shown great potential in drug delivery due to their unique characteristics of high specific surface area, good thermal conductivity, and easy surface modification. The hollow structures of fullerenes and carbon nanotubes (CNTs) could be used to carry drugs or other small molecules [73]. Large numbers of π electrons on the surface of graphene and CNTs can be used to load hydrophobic drugs [74,75].…”
Section: Carbon-based Nmsmentioning
confidence: 99%
“…Fullerenes are suitable for multiple functionalization steps according to their particular globular network structure [97]. They are widely used as excellent antioxidants [98], antiviral agents [99,100], drug and gene delivery systems [101][102][103] and photosensitizers for photodynamic therapy [104,105]. On the other hand, elongated design of carbon nanotubes diagnostic imaging strategies [106][107][108][109][110], drug delivery [111][112][113] and also photothermal therapy [114,115].…”
Section: Classification Of Npsmentioning
confidence: 99%